To evaluate the relevance of our findings to human hematopoietic diseases that result from telomere shortening, we performed the scRNA-seq analysis of Lin−CD34+ HSPCs isolated from two individuals with heterozygous pathogenic germline TERT mutations, before any clinical manifestation of hematological disorders (Supplementary Table 1). This evidence concerns the gene TERT and hematologic disorder.